-
LEVI'S® BOLSTERS DIRECT-TO-CONSUMER STRATEGY IN ASIA WITH NEW DELHI MALL STORE, THE LARGEST GLOBALLY2024-06-18 16:29
-
2024-06-17 23:00
-
2024-06-17 19:25
Net assets under management as of March 31, 2024 increase to $264.9 billion.Fiscal year ends at March 31, 2024 with one-year return of 7.2%.Ten-year net annualized return of 8.3% leads to $24.5 billion in cumulative net investment gains above Reference Portfolio, indicative of lo
-
2024-06-17 11:17
Fisher Investments' Founder KenFisherMaintains MajorityControlling InterestPLANO, Texas, June 17, 2024 /PRNewswire/ -- Fisher Investments ("FI") announced today that Advent International ("Advent") and a wholly owned subsidiary of the Abu Dhabi Investment Authority ("ADIA") have
-
2024-06-17 09:03
-
2024-06-14 22:30
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas.Ascentage Pharma to receive an option payment of 100 million USD upon closing and be eligible for an option exercise fee and additional po
-
2024-05-14 09:00
-
2024-06-12 18:16
BENGALURU, India, June 12, 2024 /PRNewswire/ -- Infosys(NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that it has been ranked, for the third consecutive year, among the 100 most valuable brands in the worl
-
2024-06-12 14:57
LILLE, France, June 12, 2024 /PRNewswire/ -- Lesaffre, an independent key global player in fermentation and microorganisms, announces today the signing of a transaction with dsm-firmenich, a leading innovator in nutrition, health and beauty, regarding its yeast extract business.L
-
2024-06-11 12:25
SUZHOU, China, and ROCKVILLE, Md., June 11, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the Center for Drug Evaluati